An immunochemical assay has been designed that utilizes the catalytic properties of glutathione-activated ficin to separate antibody-bound radioinsulin from unbound insulin I-131. Both the recovery of human insulin added to serum and the failure to detect chemically inactivated insulin provide evidence for the precision and specificity of the procedure. Measurements of endogenous insulin in serum (diluted 1:10) made after the administration of glucose or tolbutamide revealed rapid increases in circulating levels of hormone in nondiabetic subjects. The successful application of enzyme hydrolysis as the basis of a reliable and rapid immunoassay for insulin suggests that with the appropriate antibody and labeled antigen, the same principle could be employed to measure concentrations of other hormones or substances that are potentially antigenic.
Skip Nav Destination
Article navigation
Original Contributions|
September 01 1967
Use of Enzyme Proteolysis for the Immunochemical Measurement of Insulin
M L Mitchell, MD;
M L Mitchell, MD
Endocrine and Radioisotope Division of the Department of Medicine, Lemuel Shattuck Hospital and Tufts University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
John Byron, BS
John Byron, BS
Endocrine and Radioisotope Division of the Department of Medicine, Lemuel Shattuck Hospital and Tufts University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
Citation
M L Mitchell, John Byron; Use of Enzyme Proteolysis for the Immunochemical Measurement of Insulin. Diabetes 1 September 1967; 16 (9): 656–663. https://doi.org/10.2337/diab.16.9.656
Download citation file: